Acadia Pharmaceuticals (ACAD) Times Interest Earned (2018 - 2020)

Acadia Pharmaceuticals' Times Interest Earned history runs 16 years deep, the most recent figure standing at -$0.78 for Q1 2026.

• In Q1 2026, Times Interest Earned fell 358.82% year-over-year to -$0.78; the TTM figure through Mar 2026 stood at $13.68 (up 272.57% YoY), while the FY2025 annual figure was $1.32, down 87.9% from the prior year.
• Times Interest Earned for Q1 2026 stood at -$0.78, down from $5.45 in the prior quarter.
• The five-year high for Times Interest Earned was $59.64 in Q4 2024, with the low at -$19.51 in Q4 2022.
• The 5-year median for Times Interest Earned is $0.3 (2025), against an average of $3.33.
• The sharpest annual moves came in 2022 and 2024: Times Interest Earned slumped 1697.47% in 2022, then surged 6853.33% in 2024.
• Acadia Pharmaceuticals' Times Interest Earned stood at -$19.51 in 2022, then jumped by 174.82% to $14.6 in 2023, then soared by 308.56% to $59.64 in 2024, then slumped by 90.87% to $5.45 in 2025, then sank by 114.33% to -$0.78 in 2026.
• Business Quant data shows ACAD's Times Interest Earned at -$0.78 in Q1 2026, $5.45 in Q4 2025, and $3.13 in Q3 2025.